Literature DB >> 8263184

Bactericidal, virucidal, and mycobactericidal activities of reused alkaline glutaraldehyde in an endoscopy unit.

J N Mbithi1, V S Springthorpe, S A Sattar, M Pacquette.   

Abstract

Baths with 2% alkaline glutaraldehyde are often reused for 14 days to decontaminate flexible fiberoptic endoscopes (FFEs) between patients, but the effect of such reuse on the disinfectant's activity has not been known. Many busy endoscopy units also disinfect FFEs with contact times shorter than those recommended by the disinfectant manufacturer. We therefore collected samples of the disinfectant over the 14-day reuse period from two manual and one automatic bath used for bronchoscopes and gastroscopes at a local hospital. Control samples were also collected from a manual bath of 2% alkaline glutaraldehyde which did not receive any endoscopes. The germicidal activities of the samples were assessed in a carrier test against a mixture of hepatitis A virus, poliovirus 1 (Sabin), and Pseudomonas aeruginosa; the mixture also contained either Mycobacterium bovis or Mycobacterium gordonae. Bovine serum (5%) was the organic load. The criterion of efficacy was a minimum of a 3-log10-unit reduction in the infectivity titers of the organisms tested. The initial disinfectant concentration in all the baths was nearly 2.25%; it became about 1.8% in the control bath and fell to approximately 1% in the three test baths after 14 days. No protein was detected in the control bath, while its concentration rose gradually in the test baths to a maximum of 1,267 micrograms/ml after 14 days. With a contact time of 10 min at 20 +/- 2 degrees C, all the samples from the control bath were effective against all the test organisms and all the samples from all the test baths were also effective against P. aeruginosa. With a contact time of 10 or 20 min at 20+/-2 degrees C, the virucidal and mycobactericidal activities of the samples from the test baths showed broad-spectrum germicidal activity when the contact time was increased to 45 min and the temperature was raised to 25 degrees C. These findings emphasize the care needed in the disinfection of FFEs, especially in view of the increasing threat of AIDS and the resurgence of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263184      PMCID: PMC266182          DOI: 10.1128/jcm.31.11.2988-2995.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Multi-state investigation of the actual disinfection/sterilization of endoscopes in health care facilities.

Authors:  R G Kaczmarek; R M Moore; J McCrohan; D A Goldmann; C Reynolds; C Caquelin; E Israel
Journal:  Am J Med       Date:  1992-03       Impact factor: 4.965

2.  The enhancement of infection control in-service education by ward opinion leaders.

Authors:  W H Seto; T Y Ching; K Y Yuen; Y B Chu; W L Seto
Journal:  Am J Infect Control       Date:  1991-04       Impact factor: 2.918

3.  Activity of glutaraldehyde at low concentrations (less than 2%) against poliovirus and its relevance to gastrointestinal endoscope disinfection procedures.

Authors:  J L Bailly; M Chambon; H Peigue-Lafeuille; H Laveran; C De Champs; D Beytout
Journal:  Appl Environ Microbiol       Date:  1991-04       Impact factor: 4.792

Review 4.  Mycobacterial diseases other than tuberculosis.

Authors:  E Wolinsky
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

Review 5.  Disinfection of endoscopic equipment.

Authors:  A T Axon
Journal:  Baillieres Clin Gastroenterol       Date:  1991-03

6.  Disinfection practices for endoscopes and other semicritical items.

Authors:  W A Rutala; E P Clontz; D J Weber; K K Hoffmann
Journal:  Infect Control Hosp Epidemiol       Date:  1991-05       Impact factor: 3.254

7.  Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants.

Authors:  L S Rosenblum; M E Villarino; O V Nainan; M E Melish; S C Hadler; P P Pinsky; W R Jarvis; C E Ott; H S Margolis
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

8.  Case report: disseminated Mycobacterium gordonae infection in a nonimmunocompromised host.

Authors:  L N Jarikre
Journal:  Am J Med Sci       Date:  1991-12       Impact factor: 2.378

9.  Infection control practices in gastrointestinal endoscopy in the United States: a national survey.

Authors:  G J Gorse; R L Messner
Journal:  Infect Control Hosp Epidemiol       Date:  1991-05       Impact factor: 3.254

10.  Survival of hepatitis A virus on human hands and its transfer on contact with animate and inanimate surfaces.

Authors:  J N Mbithi; V S Springthorpe; J R Boulet; S A Sattar
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

View more
  7 in total

Review 1.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Virucidal agents in the eve of manorapid synergy.

Authors:  Angel S Galabov
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-09-13

3.  Identification of a contaminating Mycobacterium tuberculosis strain with a transposition of an IS6110 insertion element resulting in an altered spoligotype.

Authors:  W H Benjamin; K H Lok; R Harris; N Brook; L Bond; D Mulcahy; N Robinson; V Pruitt; D P Kirkpatrick ; M E Kimerling; N E Dunlap
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  Novel algorithm identifies species in a polymycobacterial sample by fluorescence capillary electrophoresis-based single-strand conformation polymorphism analysis.

Authors:  Tomotada Iwamoto; Toshiaki Sonobe; Kozaburo Hayashi
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 5.  Antiseptics and disinfectants: activity, action, and resistance.

Authors:  G McDonnell; A D Russell
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

6.  Synthesis and Complete Antimicrobial Characterization of CEOBACTER, an Ag-Based Nanocomposite.

Authors:  O E Jaime-Acuña; A Meza-Villezcas; M Vasquez-Peña; O Raymond-Herrera; H Villavicencio-García; V Petranovskii; R Vazquez-Duhalt; A Huerta-Saquero
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

Review 7.  American College of Chest Physicians and American Association for Bronchology [corrected] consensus statement: prevention of flexible bronchoscopy-associated infection.

Authors:  Atul C Mehta; Udaya B S Prakash; Robert Garland; Edward Haponik; Leonard Moses; William Schaffner; Gerard Silvestri
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.